Complex Decongestive Therapy of Primary Lymphedema



Complex decongestive therapy (CDT) (also known as complete decongestive therapy or decongestive lymphatic therapy (DLT)) is now well established as the standard treatment for lymphedema regardless of the etiology (primary or secondary), its site (limb, trunk, or face), or its clinical stage [1]. The best treatment protocol among whole CDT or single therapy (MLD, pneumatic pump, short-stretch bandages, compression garments, and therapeutic exercises) still could not be identified because of heterogeneity in the subject populations, measured outcomes, and follow-up durations in the current studies. Many studies have revealed the short-term and long-term benefits of CDT such as decreasing edema volume and improving quality of life (QOL) in patient with secondary lymphedema on limb [2, 3] or even head/neck area [4].


  1. 1.
    The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology. 2013;46:1–11.Google Scholar
  2. 2.
    Lasinski BB, TK mK, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012;4:580–601.CrossRefPubMedGoogle Scholar
  3. 3.
    Kim YB, Hwang JH, Kim TW, et al. Would complex decongestive therapy reveal long-term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecological cancer treatment? Gynecol Oncol. 2012;127:638–42.CrossRefPubMedGoogle Scholar
  4. 4.
    Smith BG, Hutcheson KA, Little LG, Skoracki RJ, Rosenthal DI, et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2015;152(2):284–91.CrossRefPubMedGoogle Scholar
  5. 5.
    Okajima S, Hirota A, Kimura E, et al. Health-related quality of life and associated factors in patients with primary lymphedema. Jpn J Nurs Sci. 2013;10:202–11.CrossRefPubMedGoogle Scholar
  6. 6.
    Deng J, Radina E, Fu MR, et al. Self-care status, symptom burden, and reported infections in individuals with lower-extremity primary lymphedema. J Nurs Scholarsh. 2015;47(2):126–34.CrossRefPubMedGoogle Scholar
  7. 7.
    Lee BB, Andrade M, Antignani PL, et al. Diagnosis and treatment of primary lymphedema consensus document of the international union of phlebology (IUP)-2013. Int Angiol. 2013;32(6):541–60.PubMedGoogle Scholar
  8. 8.
    Connell F, Brice G, Jeffery S, et al. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet. 2010;77:438–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Foldi E, Foldi M. Complete decongestive therapy. In: Lee BB, Bergan J, Rockson SG, editors. Lymphedema; a concise compendium of theory and practice. London: Springer; 2011. p. 220–49.Google Scholar
  10. 10.
    Zuther JE. Lymphedema management: the comprehensive guide for practitioners. 2nd ed. New York: Thieme; 2009.Google Scholar
  11. 11.
    Javid SH, Anderson BO. Mounting evidence against complex decongestive therapy as a first-line treatment for early lymphedema. J Clin Oncol. 2013;31(30):3737–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Dayes IS, Whelan TJ, Jullian JA, et al. Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer. J Clin Oncol. 2013;31:3738–63.CrossRefGoogle Scholar
  13. 13.
    Schuren J, Mohr K. Pascal’s law and the dynamics of compression therapy: a study on healthy volunteers. Int Angiol. 2010;29(5):431–5.PubMedGoogle Scholar
  14. 14.
    Leduc O, Leduc A, Bourgeois P, et al. The physical treatment of upper limb edema. Cancer. 1998;89(12 Suppl American):2835–9.CrossRefGoogle Scholar
  15. 15.
    Havas E, Paeviainen T, Vourela J, et al. Lymph flow dynamics in exercising human skeletal muscle as detected by scintigraphy. J Physiol. 1997;504:233–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Tidhar D, Drouin J, Shimony A. Aqua lymphatic therapy in managing lower extremity lymphedema. J Support Oncol. 2007;5:179–83.PubMedGoogle Scholar
  17. 17.
    Smith BG, Hutcheson KA, Little LG, et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngology-head and neck surgery. 2015;152(2):284–91.CrossRefPubMedGoogle Scholar
  18. 18.
    Szolnoky G, Lakatos B, Keskeny T, et al. Intermittent pneumatic compression acts synergistically with manual lymphatic drainage in complex decongestive physiotherapy for breast cancer treatment-related lymphedema. Lymphology. 2009;42:188–94.PubMedGoogle Scholar
  19. 19.
    Haghighat S, Lotfi-Tokaldany M, Yunesian M, Akbari ME, Nazemi F, Weiss J. Comparing two treatment methods for postmastectomy lymphedema: complex decongestive therapy alone and in combination with intermittent pneumatic compression. Lymphology. 2010;43:25–33.PubMedGoogle Scholar
  20. 20.
    Uzkeser H, Karatay S, Erdemci B, Koc M, Senel K. Efficacy of manual lymphatic drainage and intermittent pneumatic compression pump use in the treatment of lymphedema after mastectomy: a randomized controlled trial. Breast Cancer. 2015;22:300–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Morris RJ. Intermittent pneumatic compression-systems and applications. J Med Eng Technol. 2008;32(3):179–88.CrossRefPubMedGoogle Scholar
  22. 22.
    Rockson SG. Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med. 2010;15(3):223–31.CrossRefPubMedGoogle Scholar
  23. 23.
    Lee H, Uhm KE, Hwang JH. Clinical characteristics and long-term outcomes in patients with primary lymphedema. In: Proceedings of 43rd annual meeting of the Korean Academy of Rehabilitation Medicine, Seoul; 2015.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of Physical & Rehabilitation MedicineSamsung Medical Center, SungKyunKwan University School of MedicineSeoulSouth Korea

Personalised recommendations